FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


15270 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Potassium chloride 15meq Potassium chloride only product
kaliumklorid 15 milliekvivalenter per förpackning Potassium chloride only product
kaliumklorid 1 000 mg/5 ml, lösning Potassium chloride only product
kaliumklorid 1 000 mg/ml, lösning Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 %, injektionsvätska, lösning, ampull Potassium chloride 200 mg/mL solution for injection
kaliumklorid 20 %, lösning Potassium chloride only product
kaliumklorid 20 milliekvivalenter, pulver Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug)
Potassium chloride 20meq/15m solution Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 milliekvivalenter/15 ml, lösning Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumklorid 20 milliekvivalenter per förpackning Potassium chloride only product
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection
glukos 5 % + kaliumklorid 20 millimol, infusionsvätska, lösning, påse 500 ml Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1000 ml Product containing precisely potassium chloride 2 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection
glukos 5 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection
natriumklorid 0,9 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug)
kaliumklorid 7,5 %, sirap Product containing only potassium chloride in oral dose form (medicinal product form)
injektionskoncentrat kaliumklorid 15 %, lösning, ampull Product containing only potassium chloride in parenteral dose form (medicinal product form)
kaliumcitrat 12 g/10 ml koncentrerad blandning Product containing only potassium citrate in oral dose form (medicinal product form)
kaliumcitrat 12 g/10 ml, oral lösning Product containing only potassium citrate in oral dose form (medicinal product form)
kaliumcitrat 3 g/dospåse, granulat Product containing only potassium citrate in oral dose form (medicinal product form)
biverkningar av kaliumklorazepat Adverse reaction to clorazepate
kaliumglukonat 20 milliekvivalenter/15 ml, elixir Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug)
kaliumpermanganat 400 mg, tablett till kutan lösning Product containing permanganic acid in cutaneous dose form (medicinal product form)
kaliumpermanganat 400 mg, tablett till lösning Product containing permanganic acid in cutaneous dose form (medicinal product form)
kaliumfosfat 2 mmol/ml, injektionsvätska, lösning, ampull 10 ml Product containing precisely monobasic potassium phosphate 136 milligram/1 milliliter conventional release solution for injection (clinical drug)
kaliumtillskott Potassium and/or potassium compound
potatis, livsmedel Potato (substance)
potentiell exponering för infektion Exposure to organism (event)
Potential infectious contact Exposure to organism (event)
Potential infectious contact Exposure to organism (event)
Potexvirus group Genus Potexvirus (organism)
Potts fraktur Bimalleolar fracture of ankle
Pouched mammal Infraclass Metatheria (organism)
povidon 5 %, ögondroppar Povidone 50 mg/mL eye solution
povidon 5 %, ögondroppar för engångsbruk Povidone 50 mg/mL eye solution
joderad povidon 10 % Product containing povidone iodine (medicinal product)
joderad povidon 10 %, preparat för pensling Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
joderad povidon 10 %, svamp för lokalt bruk Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
joderad povidon 10 %, vaginalgel Iodine (as povidone iodine) 100 mg/g vaginal gel
joderad povidon 20 %, svamp för lokalt bruk Povidone iodine only product in cutaneous dose form
joderad povidon 200 mg, suppositorium Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug)
joderad povidon 5 %, svamp för lokalt bruk Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)
pulver till instillationslösning för luftvägarna Powder for solution for endotracheopulmonary instillation
pulver till suspension för endotrakeal instillation Powder for conventional release suspension for endotracheopulmonary instillation (dose form)
pulver till suspension Powder (basic dose form)
Powered wheelchair Motorized wheelchair device (physical object)
Poxvirus group Family Poxviridae (organism)
Pramipexole dihydrochloride 125micrograms tablet Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug)
Pramipexole dihydrochloride 1mg tablet Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet
Pramipexole dihydrochloride 250micrograms tablet Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet
pramlintid 1 mg/ml, injektionsvätska, lösning, förfylld penna Pramlintide only product
Pre-excitation atrioventricular conduction Accelerated atrioventricular conduction
befintlig terapi ändrad av anestesiolog preoperativt Pre-existing therapy altered by anesthetist preoperatively (situation)
duplexvaccination mot difteri och stelkramp i förskoleåldern Preschool administration of diphtheria and tetanus vaccine
Precautionary nursing procedure Nursing procedure
Prediabetes Impaired glucose tolerance
prednisolon 0,001 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution
prednisolon 0,003 %, ögondroppar Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,01 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution
prednisolon 0,01 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution
prednisolon 0,01 %, ögondroppar utan konserveringsmedel Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution
prednisolon 0,03 %, ögondroppar Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,03 %, ögondroppar Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,03 %, ögondroppar utan konserveringsmedel Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,1 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution
prednisolon 0,1 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution
prednisolon 0,1 %, ögondroppar utan konserveringsmedel Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution
prednisolon 0,3 %, ögondroppar Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,3 %, ögondroppar Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug)
prednisolon 0,3 %, ögondroppar utan konserveringsmedel Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug)
Prednisolone 20mg/100mL enema Prednisolone only product in rectal dose form
Prednisolone 20mg/100mL enema Prednisolone only product in rectal dose form
prednisolon 20 mg/100 ml, retentionslavemang som administreras med lång slang Prednisolone only product in rectal dose form
prednisolon 20 mg/100 ml, retentionslavemang som administreras med standardslang Prednisolone only product in rectal dose form
prednisolon 5 mg, löslig tablett Product containing precisely prednisolone 5 milligram/1 each conventional release orodispersible tablet (clinical drug)
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, salva Prednisolone and sulfacetamide only product in ocular dose form
Prednisolone acetate 25mg/mL Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug)
prednisolonacetat 25 mg/ml, suspension Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug)
allergi mot prednisolondroppar Allergy to prednisolone
prednisolonhexanoat 1,3 mg + cinkokain 1 mg, suppositorium Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug)
prednisolonnatriumfosfat 0,5 %, ögondroppar Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution
prednisolonnatriumfosfat 0,5 %, ögondroppar för engångsbruk Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution
prednisolonnatriumfosfat 1 %, lösning Product containing precisely prednisolone sodium phosphate 10 milligram/1 milliliter conventional release eye drops (clinical drug)
prednisolonnatriumfosfat 1/8 %, lösning Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug)
preferens för temperatur på dryck Preference for temperature of drink (observable entity)
preferens för temperatur på mat Preference for temperature of food (observable entity)
Preglaucoma Glaucoma suspect
substansberoende under graviditet Pregnancy and substance dependence (disorder)
förlängd graviditet-41 veckor Prolonged pregnancy (disorder)
förlängd graviditet-42 veckor Prolonged pregnancy (disorder)
Pregnancy, childbirth and puerperal disorders Disorder of pregnancy
prematur onormal placenta Premature aging of placenta
Premature ejaculation Premature ejaculation
underburet foster Prematurity of infant (disorder)

Start Previous Page 94 of 153 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start